Sale!

GLIS3 Gene Diabetes Mellitus Neonatal Genetic Test

Original price was: $700.Current price is: $500.

-29%

The GLIS3 Gene Diabetes Mellitus Neonatal NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the GLIS3 gene associated with neonatal diabetes mellitus. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of genetic variants responsible for this rare metabolic disorder. The test is specifically designed for infants presenting with diabetes symptoms within the first six months of life, helping clinicians establish precise diagnoses and develop targeted treatment strategies. At only $500 USD, this advanced genetic testing offers invaluable insights for families affected by neonatal diabetes, enabling early intervention and personalized care management. The test requires a simple blood sample or extracted DNA and provides results within 3-4 weeks, making it an essential tool for pediatric endocrinologists and genetic specialists across the United States.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

GLIS3 Gene Diabetes Mellitus Neonatal NGS Genetic DNA Test

Comprehensive Genetic Analysis for Neonatal Diabetes Diagnosis

The GLIS3 Gene Diabetes Mellitus Neonatal NGS Genetic DNA Test represents a breakthrough in pediatric genetic diagnostics, specifically designed to identify mutations in the GLIS3 gene that cause neonatal diabetes mellitus. This rare metabolic disorder affects infants within the first six months of life and requires specialized genetic testing for accurate diagnosis and management. Our advanced Next-Generation Sequencing (NGS) technology provides unparalleled accuracy in detecting genetic variants, enabling healthcare providers to develop targeted treatment plans for affected infants.

What Does the GLIS3 Gene Test Measure?

This sophisticated genetic test specifically analyzes the GLIS3 gene, which plays a crucial role in pancreatic development and insulin production. The test detects:

  • Point mutations and small insertions/deletions in the GLIS3 gene
  • Genetic variants associated with neonatal diabetes mellitus
  • Mutations affecting pancreatic beta-cell function
  • Genetic markers for congenital hypothyroidism often associated with GLIS3 mutations
  • Variants that may indicate additional syndromic features

Who Should Consider This Genetic Test?

The GLIS3 Gene Diabetes Mellitus Neonatal NGS Genetic DNA Test is recommended for:

  • Infants presenting with persistent hyperglycemia within the first six months of life
  • Newborns with unexplained failure to thrive and developmental delays
  • Patients with family history of neonatal diabetes or consanguineous parents
  • Infants showing symptoms of congenital hypothyroidism alongside diabetes
  • Cases where standard diabetes management approaches prove ineffective
  • Patients requiring genetic confirmation for treatment optimization

Key Benefits of GLIS3 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Precise Diagnosis: Accurate identification of GLIS3 gene mutations enables definitive diagnosis
  • Personalized Treatment: Genetic results guide targeted therapeutic interventions
  • Family Planning: Provides crucial information for genetic counseling and future family planning
  • Early Intervention: Facilitates timely management to prevent complications
  • Comprehensive Care: Helps identify associated conditions like congenital hypothyroidism
  • Improved Outcomes: Enables better long-term management and quality of life

Understanding Your Test Results

Our comprehensive genetic report provides clear, actionable information:

  • Positive Result: Indicates the presence of GLIS3 gene mutations associated with neonatal diabetes, requiring immediate endocrinology consultation
  • Negative Result: Suggests alternative causes for neonatal diabetes symptoms, guiding further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes requiring additional clinical correlation and possible family studies
  • Carrier Status: Provides information about genetic carrier status for family members

Test Details and Pricing

Test Component Details
Test Name GLIS3 Gene Diabetes Mellitus Neonatal NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your GLIS3 genetic test, we recommend:

  • Complete clinical history documentation of the patient
  • Genetic counseling session to create detailed family pedigree
  • Discussion of test implications and potential outcomes
  • Review of insurance coverage and payment options

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified genetic counselors and healthcare providers ensures comprehensive care regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about neonatal diabetes affect your child’s health and future. Our GLIS3 Gene Diabetes Mellitus Neonatal NGS Genetic DNA Test provides the answers you need for informed medical decisions. With our discounted price of $500 USD and comprehensive genetic analysis, you’ll receive the clarity necessary for optimal treatment planning.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Take control of your child’s health journey with definitive genetic insights from America’s trusted genetic testing provider.